Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Gutiérrez-Campos
Observed name:
David Gutierrez-Campos
Institution:
Hospital Universitario Virgen del Rocío
Observed institutions:
Consejo Superior de Investigaciones Científicas,
Hospital Universitario Virgen Macarena,
Instituto de Biomedicina de Sevilla,
Hospital Universitario Virgen del Rocío,
Universidad de Sevilla
ORCID:
0000-0001-5820-2279
Observed ORCID:
0000-0001-5820-2279
OpenAlex ID:
A5034962663
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
2023
·
Elisa Gentilotti
, Anna Górska
, et al.
·
EClinicalMedicine
·
125
PDF
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
2022
·
Milo Gatti
, Matteo Rinaldi
, et al.
·
Clinical Microbiology and Infection
·
64
Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients
2023
·
Sonsoles Salto-Alejandre
, Marta Carretero-Ledesma
, et al.
·
Journal of Infection
·
6
PDF
Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study
2024
·
Victor Garcia-Garcia
, Maria Barca-Hernando
, et al.
·
Thrombosis Research
·
2
External Validation of Bleeding Risk and Recurrent Venous Thromboembolism (VTE) Risk Scores in patients with cancer associated-thrombosis.
2025
·
Maria Barca Hernando
, Sergio Lopez-Ruz
, et al.
·
European Respiratory Journal
Impact of Residual Vein Venous Thrombosis in Consecutive Patients with Cancer-Associated Thrombosis Treated with Tinzaparin—A Cohort Study
2024
·
Carmen Rosa-Linares
, Maria Barca-Hernando
, et al.
·
Cancers
PDF
Show more works
View as search
Works count:
6
Citation count:
197
H-index:
3
I10-index:
2
Year
Topic
Type